Wedbush Securities’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.61M Sell
17,784
-1,417
-7% -$219K 0.08% 207
2025
Q4
$2.97M Buy
19,201
+1,527
+9% +$229K 0.09% 182
2025
Q3
$2.46M Buy
17,674
+399
+2% +$54K 0.08% 190
2025
Q2
$2.33M Sell
17,275
-1,329
-7% -$179K 0.08% 182
2025
Q1
$2.72M Sell
18,604
-844
-4% -$123K 0.1% 150
2024
Q4
$2.68M Sell
19,448
-3,263
-14% -$477K 0.1% 154
2024
Q3
$3.5M Sell
22,711
-15,427
-40% -$2.34M 0.13% 118
2024
Q2
$5.56M Sell
38,138
-1,445
-4% -$207K 0.2% 75
2024
Q1
$5.85M Sell
39,583
-4,840
-11% -$694K 0.22% 73
2023
Q4
$6.06M Sell
44,423
-7,567
-15% -$984K 0.27% 61
2023
Q3
$6.69M Buy
51,990
+3,613
+7% +$480K 0.33% 53
2023
Q2
$6.42M Buy
48,377
+1,774
+4% +$234K 0.31% 60
2023
Q1
$6.03M Sell
46,603
-3,431
-7% -$448K 0.3% 59
2022
Q4
$6.8M Buy
50,034
+4,068
+9% +$539K 0.37% 46
2022
Q3
$5.57M Sell
45,966
-1,204
-3% -$155K 0.31% 50
2022
Q2
$6.05M Sell
47,170
-608
-1% -$79.7K 0.33% 50
2022
Q1
$6.54M Buy
47,778
+4,646
+11% +$615K 0.3% 51
2021
Q4
$6.08M Buy
43,132
+12,859
+42% +$1.71M 0.26% 57
2021
Q3
$3.85M Buy
30,273
+534
+2% +$70.6K 0.18% 87
2021
Q2
$3.75M Buy
29,739
+260
+0.9% +$31.9K 0.18% 93
2021
Q1
$3.44M Buy
29,479
+3,886
+15% +$449K 0.19% 86
2020
Q4
$2.9M Buy
25,593
+56
+0.2% +$6.11K 0.25% 77
2020
Q3
$2.69M Buy
25,537
+1,204
+5% +$127K 0.26% 81
2020
Q2
$2.44M Buy
24,333
+484
+2% +$47.8K 0.23% 98
2020
Q1
$2.11M Buy
23,849
+881
+4% +$85.6K 0.25% 90
2019
Q4
$2.34M Buy
22,968
+155
+0.7% +$14.9K 0.21% 106
2019
Q3
$2.06M Sell
22,813
-1,005
-4% -$91.8K 0.2% 113
2019
Q2
$2.21M Buy
23,818
+1,217
+5% +$109K 0.22% 98
2019
Q1
$2.07M Buy
22,601
+3,809
+20% +$343K 0.22% 102
2018
Q4
$1.63M Buy
18,792
+6,224
+50% +$563K 0.21% 116
2018
Q3
$1.2M Sell
12,568
-240
-2% -$21.7K 0.14% 172
2018
Q2
$1.07M Sell
12,808
-163
-1% -$13.5K 0.13% 179
2018
Q1
$1.06M Sell
12,971
-325
-2% -$27.7K 0.14% 174
2017
Q4
$1.1M Buy
13,296
+23
+0.2% +$1.9K 0.13% 180
2017
Q3
$1.08M Buy
13,273
+677
+5% +$54.4K 0.14% 157
2017
Q2
$998K Buy
12,596
+536
+4% +$40.8K 0.13% 193
2017
Q1
$897K Buy
12,060
+361
+3% +$26.3K 0.12% 202
2016
Q4
$807K Buy
11,699
+1,286
+12% +$89.3K 0.12% 213
2016
Q3
$751K Sell
10,413
-757
-7% -$55.7K 0.11% 204
2016
Q2
$801K Buy
11,170
+1,417
+15% +$99.8K 0.13% 166
2016
Q1
$661K Sell
9,753
-1,430
-13% -$95.8K 0.11% 196
2015
Q4
$806K Sell
11,183
-2,560
-19% -$181K 0.15% 156
2015
Q3
$910K Buy
13,743
+958
+7% +$70K 0.18% 128
2015
Q2
$951K Buy
12,785
+396
+3% +$29.3K 0.18% 135
2015
Q1
$898K Buy
12,389
+7,508
+154% +$536K 0.15% 147
2014
Q4
$334K Buy
4,881
+1,352
+38% +$90.5K 0.05% 372
2014
Q3
$226K Buy
+3,529
New +$221K 0.04% 496
2014
Q2
Sell
-3,557
Closed -$208K 686
2014
Q1
$208K Buy
+3,557
New +$205K 0.04% 499

Other funds holding XLV

Wedbush Securities's XLV Position: Q1 2026 in Review

Wedbush Securities reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 7.4% in Q1 2026, selling an estimated $219K and leaving 17,784 shares worth $2.61M. The position accounts for 0.08% of the portfolio, ranked #207.

Wedbush Securities first reported a position in XLV in Q1 2014 and has held it in 48 quarters since. The position peaked at $6.8M in Q4 2022. 1,804 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • Wedbush Securities held 17,784 shares of State Street Health Care Select Sector SPDR ETF worth $2.61M as of Q1 2026.
  • Wedbush Securities sold 1,417 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $219K.
  • State Street Health Care Select Sector SPDR ETF made up 0.08% of Wedbush Securities's portfolio in Q1 2026, its #207 holding.
  • Wedbush Securities first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2014 and has held it in 48 quarters since.
  • Wedbush Securities's State Street Health Care Select Sector SPDR ETF position peaked at $6.8M in Q4 2022.
  • 1,804 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.